IQVIA™ Real-World Insights Bibliography

Utility and Willingness to Pay for Lung Cancer Treatments: Patient Versus General Population Values in Thailand.
Author(s): Thongprasert S, Permsuwan U, Sakulbumrungsil R, Chaiyakunapruk N, Crawford B, Petcharapiruch S1, Leartsakulpanitch J.
Affiliations(s): 1Outcomes Resarch, Medical Department, Pfizer (Thailand) Limited, Thailand
Publication(s):  HTAi (June 17 – 19, 2013, Seoul Korea).
Document Type(s): Poster,
Countries: Thailand,
Click here for the abstract
C:
Y:
Oncology,
2013
  L:
A:
English
Economic evaluation,
  Add to report
 
 
The cost-effectiveness of travoprost preserved with polyquad® in newly treated open-angle glaucoma patients in 7 Asian countries.
Author(s): Gerlier L1, Lamotte M1, Caputo J2, Tan R3
Affiliations(s): 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore
Publication(s):  5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan
Document Type(s): Abstract, Poster,
Countries: India, Malaysia, Singapore, South Korea, Thailand,
C:
Y:
Ophthalmology,
2012
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Medical resource use and associated costs in open-angle glaucoma in 10 Asia-pacific countries.
Author(s): Gerlier L1, Lamotte M1, Caputo J2, Tan R3
Affiliations(s): 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore
Publication(s):  5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan
Document Type(s): Abstract, Poster,
Countries: Australia, China, Hong Kong, India, Malaysia, New Zealand, Singapore, South Korea, Taiwan, Thailand,
C:
Y:
Ophthalmology,
2012
  L:
A:
English
Burden of illness,
  Add to report